PR Newswire PLANO, Texas, Jan. 23, 2025 The partnership increases availability to advanced breast cancer treatment and surgical services. PLANO, Texas, Jan. 23, 2025 /PRNewswire-PRWeb/ -- Specialized breast oncology practice Complete ...
PR Newswire AUSTIN, Texas, Jan. 23, 2025 Expects to Complete Enrollment of First 25 Patients in Phase 2 Expansion Study During Second Half of 2025 for Interim Analysis Acclaim-3 Study Has FDA Orphan Drug and Fast Track Designations ...
PR Newswire WESTBROOK, Maine, Jan. 23, 2025 Panel expansion planned over the next three years to cover the majority of canine cancer cases, transforming cancer detection and supporting earlier intervention WESTBROOK, Maine, Jan. 23, 2025 ...
PR Newswire CHENGDU, China, Jan. 23, 2025 CHENGDU, China, Jan. 23, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in China from National ...
PR Newswire HONG KONG, Jan. 22, 2025 HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the prestigious medical journal Nature Medicine published the results of the company's ...
PR Newswire VANCOUVER, BC, Jan. 22, 2025 VANCOUVER, BC, Jan. 22, 2025 /PRNewswire/ - Initio Medical Group marks a significant milestone in Canadian healthcare by being Western Canada's first to purchase and install the innovative GE ...
PR Newswire VANCOUVER, BC, Jan. 22, 2025 USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. 22, 2025 /PRNewswire/ -- USA News Group News Commentary – Big developments are expected this week ...
PR Newswire SAN DIEGO and CALGARY, AB, Jan. 22, 2025 Pelareorep combination therapy shows continued meaningful improvement over checkpoint inhibitors alone in anal cancer patients Pelareorep-based therapy demonstrates strong safety ...
PR Newswire BOSTON, Jan. 21, 2025 BOSTON, Jan. 21, 2025 /PRNewswire/ -- Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from its Phase I/II CLINCH study ongoing in China and ...
PR Newswire SAN DIEGO, Jan. 21, 2025 SAN DIEGO, Jan. 21, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology ...
While prostate cancer statistics may seem daunting, advances in detection, treatment, and active surveillance offer patients better outcomes.
Ubiquitin-specific proteases play a critical role in regulating cell death pathways in breast cancer, affecting tumor survival, metastasis, and response to therapy.
New research links metabolism to aggressive breast cancer progression, highlighting the role of insulin resistance and exosomes in worsening outcomes for cancer patients.
Targeted alpha therapy shows promise in treating neuroendocrine tumours, offering hope where beta therapies fall short.
Discover why cancer risk increases with age, exploring genetic changes, weakened immunity, and lifestyle factors affecting elderly and middle-aged individuals.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers